ArticleClinical obesity2026

Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information-Based Mapping Exercises Across the 42 Integrated Care Boards of England.

Anne de Bray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.